Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Breast Neoplasms 46Lung Neoplasms 29Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 16Uterine Cervical Neoplasms 9Fatigue 9Hematologic Neoplasms 8Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Anxiety Disorders 7Papillomavirus Infections 6Melanoma 6Neoplasm Metastasis 5Multiple Myeloma 5Gastrointestinal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Skin Neoplasms 4Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Depression 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Tomography, Emission-Computed, Single-Photon 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Abnormalities, Radiation-Induced × Educational Status × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡